Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe
Clinical trial NCT03547271 · COMPLETED
Trial details
- NCT number
- NCT03547271
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-14
- Primary completion
- 2023-05-17
- Enrollment
- 1660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.